$0.94
Ocean Biomedical is a biotechnology business based in the US. Ocean Biomedical shares (OCEA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.00 – an increase of 1.01% over the previous week.
What's in this guide?
Our top picks for where to buy Ocean Biomedical stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Ocean Biomedical stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – OCEA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Ocean Biomedical stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Ocean Biomedical stock price (NASDAQ: OCEA)
Use our graph to track the performance of OCEA stocks over time.Ocean Biomedical shares at a glance
Latest market close | $1.00 |
---|---|
52-week range | $0.52 - $7.79 |
50-day moving average | $1.00 |
200-day moving average | $1.51 |
Wall St. target price | $18.50 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-3.00 |
Is it a good time to buy Ocean Biomedical stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Ocean Biomedical price performance over time
Historical closes compared with the close of $1.01 from 2024-10-18
1 week (2024-10-16) | 2.02% |
---|---|
1 month (2024-09-23) | 12.22% |
3 months (2024-07-23) | -11.40% |
6 months (2024-04-23) | -31.76% |
1 year (2023-10-23) | -41.62% |
---|---|
2 years (2022-10-19) | N/A |
3 years (2021-10-19) | N/A |
5 years (2019-10-19) | N/A |
Ocean Biomedical financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -681.99% |
Return on equity TTM | 0% |
Profit margin | 0% |
Book value | $-2.21 |
Market Capitalization | $37.4 million |
TTM: trailing 12 months
Ocean Biomedical share dividends
We're not expecting Ocean Biomedical to pay a dividend over the next 12 months.
You may also wish to consider:
Ocean Biomedical share price volatility
Over the last 12 months, Ocean Biomedical's shares have ranged in value from as little as $0.52 up to $7.79. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Ocean Biomedical's is 1.512. This would suggest that Ocean Biomedical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Ocean Biomedical's beta into context you can compare it against those of similar companies.
- Biogen (BIIB.US): -0.06
- Moderna (MRNA.US): 1.661
- BioNTech (BNTX.US): 0.245
Ocean Biomedical overview
Ocean Biomedical, Inc. , a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. It is also developing three product candidates based on the WPDS platform, including a malaria vaccine candidate; a humanized mAb malaria therapeutic candidate targeting Plasmodium falciparum glutamic-acid-rich protein (PfGARP); and a small molecule malaria therapeutic candidate targeting PfGARP. The company is based in Providence, Rhode Island. Ocean Biomedical, Inc. operates as a subsidiary of Poseidon Bio, LLC.
Frequently asked questions
What percentage of Ocean Biomedical is owned by insiders or institutions?Currently 71.989% of Ocean Biomedical shares are held by insiders and 11.622% by institutions. When does the fiscal year end for Ocean Biomedical?
Ocean Biomedical's fiscal year ends in December. Where is Ocean Biomedical based?
Ocean Biomedical's address is: Room 325, 55 Claverick Street, Providence, RI, United States, 02903 What is Ocean Biomedical's ISIN number?
Ocean Biomedical's international securities identification number is: US67644C1045
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question